107 related articles for article (PubMed ID: 19200035)
1. Active form of neuroprotective Humanin, HN, and inactive analog, S7A-HN, are monomeric and disordered in aqueous phosphate solution at pH 6.0; No correlation of solution structure with activity.
Arisaka F; Arakawa T; Niikura T; Kita Y
Protein Pept Lett; 2009; 16(2):132-7. PubMed ID: 19200035
[TBL] [Abstract][Full Text] [Related]
2. The biological activity of Humanin analogs correlates with structure stabilities in solution.
Arakawa T; Niikura T; Kita Y
Int J Biol Macromol; 2011 Jul; 49(1):93-7. PubMed ID: 21510972
[TBL] [Abstract][Full Text] [Related]
3. Structure of three Humanin peptides with different activities upon interaction with liposome.
Hirano A; Shiraki K; Niikura T; Arakawa T; Kita Y
Int J Biol Macromol; 2011 Mar; 48(2):360-3. PubMed ID: 21215775
[TBL] [Abstract][Full Text] [Related]
4. The structure analysis of Humanin analog, AGA-(C8R)HNG17, by circular dichroism and sedimentation equilibrium: comparison with the parent molecule.
Arisaka F; Niikura T; Arakawa T; Kita Y
Int J Biol Macromol; 2008 Aug; 43(2):88-93. PubMed ID: 18456318
[TBL] [Abstract][Full Text] [Related]
5. Inactive C8A‑humanin analog is as stable as a potent S14G‑humanin analog.
Arakawa T; Niikura T; Kita Y
Mol Med Rep; 2014 Jan; 9(1):375-9. PubMed ID: 24247787
[TBL] [Abstract][Full Text] [Related]
6. Humanin antagonists: mutants that interfere with dimerization inhibit neuroprotection by Humanin.
Hashimoto Y; Terashita K; Niikura T; Yamagishi Y; Ishizaka M; Kanekura K; Chiba T; Yamada M; Kita Y; Aiso S; Matsuoka M; Nishimoto I
Eur J Neurosci; 2004 May; 19(9):2356-64. PubMed ID: 15128389
[TBL] [Abstract][Full Text] [Related]
7. Solution structure of Ser14Gly-humanin, a potent rescue factor against neuronal cell death in Alzheimer's disease.
Benaki D; Zikos C; Evangelou A; Livaniou E; Vlassi M; Mikros E; Pelecanou M
Biochem Biophys Res Commun; 2006 Oct; 349(2):634-42. PubMed ID: 16945331
[TBL] [Abstract][Full Text] [Related]
8. Structural preferences of neuroprotective S14G-humanin peptide analyzed by molecular modeling and circular dichroism.
Rojo-Domínguez A; Ramírez-Galicia G; Havel J; Gutiérrez-González LH
Protein Pept Lett; 2007; 14(6):618-24. PubMed ID: 17627606
[TBL] [Abstract][Full Text] [Related]
9. A rescue factor for Alzheimer's diseases: discovery, activity, structure, and mechanism.
Arakawa T; Kita Y; Niikura T
Curr Med Chem; 2008; 15(21):2086-98. PubMed ID: 18781936
[TBL] [Abstract][Full Text] [Related]
10. D-Ser-containing humanin shows promotion of fibril formation.
Hayashi K; Sasabe J; Chiba T; Aiso S; Utsunomiya-Tate N
Amino Acids; 2012 Jun; 42(6):2293-7. PubMed ID: 21735222
[TBL] [Abstract][Full Text] [Related]
11. In vitro binding and in vivo biodistribution studies of the neuroprotective peptide humanin using [125I]humanin derivatives.
Evangelou A; Zikos C; Benaki D; Pelecanou M; Bouziotis P; Papadopoulos M; Borovickova L; Vesela I; Elbert T; Kunesová G; Pirmettis I; Paravatou-Petsotas M; Slaninová J; Livaniou E
Peptides; 2009 Dec; 30(12):2409-17. PubMed ID: 19666070
[TBL] [Abstract][Full Text] [Related]
12. Two serine residues distinctly regulate the rescue function of Humanin, an inhibiting factor of Alzheimer's disease-related neurotoxicity: functional potentiation by isomerization and dimerization.
Terashita K; Hashimoto Y; Niikura T; Tajima H; Yamagishi Y; Ishizaka M; Kawasumi M; Chiba T; Kanekura K; Yamada M; Nawa M; Kita Y; Aiso S; Nishimoto I
J Neurochem; 2003 Jun; 85(6):1521-38. PubMed ID: 12787071
[TBL] [Abstract][Full Text] [Related]
13. A humanin derivative, S14G-HN, prevents amyloid-beta-induced memory impairment in mice.
Tajima H; Kawasumi M; Chiba T; Yamada M; Yamashita K; Nawa M; Kita Y; Kouyama K; Aiso S; Matsuoka M; Niikura T; Nishimoto I
J Neurosci Res; 2005 Mar; 79(5):714-23. PubMed ID: 15678515
[TBL] [Abstract][Full Text] [Related]
14. Humanin Specifically Interacts with Amyloid-β Oligomers and Counteracts Their in vivo Toxicity.
Romeo M; Stravalaci M; Beeg M; Rossi A; Fiordaliso F; Corbelli A; Salmona M; Gobbi M; Cagnotto A; Diomede L
J Alzheimers Dis; 2017; 57(3):857-871. PubMed ID: 28282805
[TBL] [Abstract][Full Text] [Related]
15. Activity-dependent neurotrophic factor, ADNF, determines the structure characteristics of Colivelin, a fusion protein of ADNF9 and Humanin analog.
Arakawa T; Niikura T; Arisaka F; Kita Y
J Pept Sci; 2008 May; 14(5):631-6. PubMed ID: 17994638
[TBL] [Abstract][Full Text] [Related]
16. Humanin ameliorates diazepam-induced memory deficit in mice.
Murakami M; Nagahama M; Maruyama T; Niikura T
Neuropeptides; 2017 Apr; 62():65-70. PubMed ID: 27814910
[TBL] [Abstract][Full Text] [Related]
17. Humanin structural versatility and interaction with model cerebral cortex membranes.
Pistolesi S; Rossini L; Ferro E; Basosi R; Trabalzini L; Pogni R
Biochemistry; 2009 Jun; 48(22):5026-33. PubMed ID: 19378954
[TBL] [Abstract][Full Text] [Related]
18. CE study of neuroprotective humanin peptide and its derivatives: interactions with phosphate, sulphate, alkylsulphonates and sulphated-beta-CD.
Havel J; Li R; Macka M
Electrophoresis; 2008 Feb; 29(3):665-71. PubMed ID: 18203257
[TBL] [Abstract][Full Text] [Related]
19. The secondary structure analysis of a potent Ser14Gly analog of antiAlzheimer peptide, Humanin, by circular dichroism.
Arakawa T; Niikura T; Tajima H; Kita Y
J Pept Sci; 2006 Oct; 12(10):639-42. PubMed ID: 16835886
[TBL] [Abstract][Full Text] [Related]
20. Structure changes of natively disordered Humanin in the presence of lipid.
Hirano A; Shiraki K; Niikura T; Arakawa T; Kita Y
Int J Biol Macromol; 2010 Apr; 46(3):375-9. PubMed ID: 20116397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
